A three-year review of pseudomonia aeruginosa infection resistance pattern among adult patients at a tertiary hospital in Cavite, Philippines

Publication Date

2018

Document Type

Research

Abstract

A descriptive study was conducted. Review of chart over a 3-year period from January 1, 2014 to December 31, 2016 was done. Both clinical and epidemiological information were obtained from the medical records of each patient. Patients were described using Percentage distribution for categorical variables and Mean for quantitative variables. A total number of 79 samples yielded significant growth of Pseudomonas aeruginosa from January 1, 2014 to December 31, 2016 were included in this study. Majority were 61 years old and above. The isolates were most frequently recovered from respiratory (sputum, endotracheal and tracheostomy) 67.1%; followed by Wound 11.4%; Blood 11.4%; and Urine 10.1%. The rate of resistance increased significantly against tested antimicrobials from 2014 to 2016; Ceftazidime 15.8% to 18.9%; Cefepime 15.8% to 21.6%; Piperacillin Tazobactam 26.3% to 29.7%; Imipenem 10.6% to 37.8%; Meropenem 15.8% to 37.8%. A decrease in Pseudomonas aeruginosa resistance to: Gentamicin 47.4% to 18.9%; Amikacin 36.8% to 16.2%; Tobramycin 42.1% to 16.2%; Ciprofloxacin 42.2% to 27%. Treatment cure had favorable outcome.

This document is currently not available here.

Share

COinS